/The%20CoreWeave%20logo%20displayed%20on%20a%20smartphone%20screen_%20Image%20by%20Robert%20Way%20via%20Shutterstock_.jpg)
/AI%20(artificial%20intelligence)/OpenAI%2C%20Stability%20AI%2C%20AI21%20Labs%2C%20Anthropic%2C%20and%20Deepmind%20logos%20are%20seen%20on%20their%20websites%20on%20a%20computer%20by%20Tada%20Images%20via%20Shutterstock.jpg)
While WEC Energy has underperformed relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
/Globe%20Life%20Logo%20on%20Phone%20Screen%2C%20Company%20Icon%20By%20Postmodern%20Studio.jpeg)
Despite Globe Life’s outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
/Progressive%20insurance%20office%20headquarters%20entrance%20sign%20in%20Tampa%2C%20Florida%20By%20Kristina%20Blokhin.jpeg)
While Progressive stock has underperformed the broader market over the past year, Wall Street remains optimistic about the stock.
Although Danaher has underperformed relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.
The market fundamentals for beef are getting tighter. Here’s what sparked the latest Tyson plant closures.
/Otis%20Worldwide%20Corporation%20on%20screen%20in%20front%20By%20Timon.jpeg)
While Otis Worldwide has underperformed the broader market over the past year, Wall Street analysts are moderately optimistic about the stock’s prospects.
SOFI is down over 30% for the year despite reporting stellar earnings, as fears of high inflation and the expected rate hikes are keeping a lid on the stock.
/Builders%20FirstSource%20Exterior%20and%20Trademark%20Logo%20By%20Wolterke.jpeg)
Builders FirstSource has considerably underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
/Zimmer%20Biomet%20headquarters_By%20jetcityimage.jpeg)
Zimmer Biomet has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.
Humana has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.
